The risks of mobility and self-care disability were highest for patients with brain, bone, and pancreatic cancer. US cancer survivors are more likely than the general population to have a mobility or ...

Treatment with DD01 treatment reduced hepatic steatosis by more than 50% in 4 weeks, according to phase 1 data. The Food and Drug Administration (FDA) has granted Fast Track designation to DD01 for ...

Ultrasound assessment, particularly using the musculoskeletal ultrasound features-based score, may aid in predicting and managing gout flares, potentially improving patient outcomes and guiding ...

The Food and Drug Administration (FDA) has approved Pivya (pivmecillinam) for the treatment of female patients 18 years of age and older with uncomplicated urinary tract infections (UTIs) caused ...

Urinary chemokines CXCL9 and CXCL10 appear to be good noninvasive biomarkers of kidney transplant rejection that can identify patients who warrant biopsy. Quantifying the inflammatory chemokines CXCL9 ...

Iron deficiency is associated with increased risk for death among patients initiating peritoneal dialysis, even if they have not been diagnosed with anemia. The death risk associated with iron ...

Chronicity on kidney biopsy, not sex, predicts the risk of progression to ESKD at 12 months after diagnosis of AAV in patients with severe kidney disease. Progression to kidney failure at 12 months in ...

Among the patients studied with chronic cough post-COVID-19, 47.1% were newly diagnosed with asthma and 18.8% with obstructive pulmonary ventilation dysfunction. Post-COVID-19 chronic cough may be ...